|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-12-2
|
|
pubmed:abstractText |
Ulcerative colitis (UC) is a chronic inflammatory disease with relapses. Many patients need systemic corticosteroids to induce clinical remission.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1876-4479
|
|
pubmed:author |
pubmed-author:BinelliDD,
pubmed-author:BouhnikYY,
pubmed-author:BrunnerHH,
pubmed-author:D'HaensG RGR,
pubmed-author:Di StefanoA F DAF,
pubmed-author:KovácsAA,
pubmed-author:Lavergne-SloveAA,
pubmed-author:MarteauPP,
pubmed-author:MolnárTT,
pubmed-author:NagyFF,
pubmed-author:VergauwePP,
pubmed-author:WeissWW
|
|
pubmed:copyrightInfo |
Copyright © 2009 Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
153-60
|
|
pubmed:meshHeading |
pubmed-meshheading:21122499-Administration, Oral,
pubmed-meshheading:21122499-Adult,
pubmed-meshheading:21122499-Anti-Inflammatory Agents,
pubmed-meshheading:21122499-Biological Markers,
pubmed-meshheading:21122499-Biopsy,
pubmed-meshheading:21122499-Budesonide,
pubmed-meshheading:21122499-C-Reactive Protein,
pubmed-meshheading:21122499-Colitis, Ulcerative,
pubmed-meshheading:21122499-Colonoscopy,
pubmed-meshheading:21122499-Double-Blind Method,
pubmed-meshheading:21122499-Drug Administration Schedule,
pubmed-meshheading:21122499-Female,
pubmed-meshheading:21122499-Humans,
pubmed-meshheading:21122499-Intestinal Mucosa,
pubmed-meshheading:21122499-Male,
pubmed-meshheading:21122499-Middle Aged,
pubmed-meshheading:21122499-Pilot Projects,
pubmed-meshheading:21122499-Remission Induction,
pubmed-meshheading:21122499-Severity of Illness Index,
pubmed-meshheading:21122499-Tablets, Enteric-Coated,
pubmed-meshheading:21122499-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
|
|
pubmed:affiliation |
Gastroenterology Dept., Imelda Hospital, Bonheiden, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
